The Application Notebook
Whole column imaging detection capillary isoelectric focusing (iCIEF) has been recognized as a powerful tool for biopharmaceutical development and quality control. Unlike conventional single point detection capillary electrophoresis (CE) systems, in which light absorbance or emission at a specific point along the separation capillary is monitored, iCIEF detects a line of light that is passed through and radiates from the entire separation capillary. As a result, sequential snapshots of the whole separation capillary at different times are obtained. This allows sample separation and interaction in real time to be observed during electrophoresis, enabling fast analytical method development, high resolution separation, and high sample throughput.
Advanced Electrophoresis Solutions Ltd.
Whole column imaging detection capillary isoelectric focusing (iCIEF) has been recognized as a powerful tool for biopharmaceutical development and quality control. Unlike conventional single point detection capillary electrophoresis (CE) systems, in which light absorbance or emission at a specific point along the separation capillary is monitored, iCIEF detects a line of light that is passed through and radiates from the entire separation capillary. As a result, sequential snapshots of the whole separation capillary at different times are obtained. This allows sample separation and interaction in real time to be observed during electrophoresis, enabling fast analytical method development, high resolution separation, and high sample throughput.
The detection sensitivity of iCIEF is determined by the detection wavelength and the length of the detection light path. The detection wavelength for normal capillary isoelectric focusing (CIEF) is 280 nm because of the relatively strong background of carrier ampholytes (a synthetic amphoteric mixture that forms a pH gradient under an electric field). Using a large inner diameter (i.d.) separation capillary allows for improved detection sensitivity before the commercial availability of low UV 214 nm carrier ampholytes. Recently, a CEInfinite cartridge series with 200 µm i.d. capillaries has been developed. These cartridges are shown to have various advantages such as low resistance for sample injections and less cartridge clogging, in addition to a sensitivity improvement over cartridges with a 100-µm i.d. capillary (refer to Figure 1).
Figure 1: Separation of a fusion protein sample with different internal diameter cartridges (red trace, 100 micrometer capillary; blue trace, 200 micrometer capillary). iCIEF method conditions: 1 min focusing period using 1500 V, 5 min focusing period using 3000 V; detection at 280 nm. Sample conditions: 0.2 mg/mL fusion protein in 1% Aeslyte HR 3 -10, 3% HR 6 - 7.5, 4M urea.
The resolution of an iCIEF system is mainly determined by the quality of the optical imaging subsystem, including the imaging sensor and focusing lens. It may also be affected by the scan rate of the imaging sensor. Imaging blur can occur as the result of slow scanning of a moving object. The application of a highly sensitive and high scan rate scientific CMOS imaging sensor can effectively improve the resolution of an iCIEF system, enabling investigation of dynamic processes with CEInfinite.
The isoelectric point (pI) of a protein is useful for protein identification and quality control. The pI of a protein can be calibrated conveniently with two pI markers in iCIEF. When used under enzymatic conditions, non-peptide synthetic small molecule pI markers are preferred to avoid losing peaks as would occur with peptide pI markers. The CEInfinite product line includes the most comprehensive, well spaced, and well calibrated pI markers on the market, covering a broad pH range from 2.5 to 10.5.
The successful application of iCIEF for charge-based protein profiling, identification, and potency assays has raised the need to further characterize protein charge variants with orthogonal techniques. Preparative iCIEF and iCIEF coupled to mass spectrometry (iCIEF-MS) are two highly demanded techniques, which can be accomplished using the CEInfinite system along with its proprietary separation cartridges. One example is fractionation of haemoglobin variants with CEInfinite (refer to Figure 2). The focused protein zones inside the separation capillary were continuously pushed out to the outlet transfer capillary after the desired CIEF separation, and collected into different vials. The high resolution CIEF separation achieved with the larger inner diameter separation capillary is maintained, as each protein zone is transferred into the smaller inner diameter transfer capillary. The collected protein variants (haemoglobin AFSC) were analyzed with iCIEF to confirm the resolution of the fractionation. The purified proteins can also be characterized with UHPLC–MS, and molecular weight and structure information can be obtained. Better fractionation resolution can be expected using shorter collection intervals. The separation capillary completes the electrical circuit for CIEF. As a result, the eluent out of the transfer capillary is separated from the electrical current - this makes it simpler and more straightforward to couple CEInfinite to a mass spectrometer when compared to conventional CE.
Figure 2: Preparative iCIEF and confirmation of fractionation collection with CEInfinite.
Advanced Electrophoresis Solutions Ltd.
1600 Industrial Rd, Cambridge, ON, N3H 4W5, Canada
Tel.: 1 518 653 6888 Fax: 1 519 804 4266
E-mail: sales@aeslifesciences.com
Website: www.aeslifesciences.com
GC–TOF-MS Finds 250 Volatile Compounds in E-Cigarette Liquids
November 1st 2024A study has used gas chromatography coupled to a time-of-flight mass spectrometer to build an electron ionization mass spectra database of more than 250 chemicals classified as either volatile or semi-volatile compounds. An additional, confirmatory layer of liquid chromatography–mass spectrometry analysis was subsequently performed.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Multivariate Design of Experiments for Gas Chromatographic Analysis
November 1st 2024Recent advances in green chemistry have made multivariate experimental design popular in sample preparation development. This approach helps reduce the number of measurements and data for evaluation and can be useful for method development in gas chromatography.